Simone Rizzetto
🚨 Update on $HCA (HCA Holdings Inc) 🚨 One of our largest position, $HCA, just released Q3 earnings and it is up ~5% in the pre-market. βœ… Positive results and Increased guidance - Revenue jumped 9.6% year-over-year to $19.161 billion. - Net income attributable to HCA rose 29.4% to $1.643 billion, or $6.96 EPS, up from $4.88 last year. - Adjusted EBITDA grew 18.5% to $3.870 billion. - Cash flow from operations hit $4.416 billion, up from $3.515 billion. - Same-facility admissions +2.1%, equivalent admissions +2.4%. - Same facility revenue per equivalent admission increased 6.6%. - Revenue guidance revised from $74.0-$76.0 billion β†’ $75.0-$76.5 billion. - Net income guidance new range: $6.495-$6.715 billion. - EPS (diluted) raised from $25.50-$27.00 β†’ $27.00-$28.00. πŸ” My comments - $HCA has been one of our top driver this year and helped reducing volatility as it often moved in opposite direction with $SPX500 . - It navigated the uncertainty around policy change regarding medicaid in US. My opinion is that new changes are squeezing out small hospitals that relies on government subsidies to operate. This is helping $HCA to increase market share in the US market. - The stock is also driven by aging population which could continue to push $HCA earnings higher in the future. - High insurance costs and in general the high cost of healthcare in US are risks that could affect negatively this stock, on the other hand the raise of AI and robotics in healthcare can help to optimize processes and increase margins.
null
.